Chinese Journal of Cardiology 2007 Issue 11 To standardize the screening,diagnosis and treatment of pulmonary arterial hypertension (no abstract)

To standardize the screening,diagnosis and treatment of pulmonary arterial hypertension (no abstract)
HU Da-yi;JING Zhi-cheng

..............page:977-978

zhu ming de xin xue guan bing xue jia lin chuan zuo jiao shou shi shi

..............page:1066

zhong hua yi xue za zhi ying wen ban chuang kan 120 zhou nian zai jing zhuan jia zuo tan hui zhao kai

..............page:1040

Function and modulation of endothelial progenitor cells (no abstract )
YU Yang;HUANG Lan

..............page:1067-1069

The progress in genetics of pulmonary arterial hypertension( no abstract)
ZHANG Wei;JING Zhi-cheng

..............page:1063-1066

ou zhou xin zang bing nian hui xue shu hui yi re dian bao dao
hu da yi

..............page:1058-1062

Propofol associated with hypokalemia causes electro storm (no abstract)
yu jian hua ; hong kui ; cheng kai cheng ; chen zuo ; ge xia guang ; su hai ; wu qing hua ; cheng xiao shu ;pedro brugada;ramon brugada

..............page:1057

Rosiglitazone enhances the anti-atherosclerotic effects of peroxisome proliferator-activated receptor γ1 gene transfer in Apolipoprotein-knock out mice
HU Qin;ZHANG Yun;ZHANG Xian-jun;ZHANG Cheng;HE Hong;ZHU Qing;JIANG Gui-hua;JING Ma;JIANG Hong;LIU Chun-xi;FENG Jin-bo

..............page:1050-1056

du zhe zuo zhe bian zhe

..............page:1004

shi xing xin lv shi chang de lin chuang chu li ce lue
huang yong zuo

..............page:1070-1072

Simvastatin downregulates CD40L induced vascular cell adhesion molecule-1 expression and adhesive function in human umbilical vein endothelial cells
ZHANG Min;FANG Wei-yi;YUAN Fang;CHEN Hui;LU Guo-ping

..............page:1046-1049

Cardioprotective effects of atovastatin preconditioning via iNOS upregulation in a rabbit ischemia/reperfusion model
ZHOU Yi;CHEN Man-hua;LIU Jin-hua

..............page:1041-1045

Protective effects of recombinant SCR15-18 domain of human soluble complement receptor type 1 on myocardial ischemia and reperfusion injury
TAN Bing;LAN Yang-jun;ZHANG De-chun;WANG Zheng-qing

..............page:1037-1040

12 li yan zhong xin li shuai jie de guan xin bing huan zhe de jie ru zhi liao
jiang dong ju ; hu gao pin ; fu rong ; gao xiao jian ; jia yu lin ; wang dong dong ; tao ai ping

..............page:1034-1036

Efficacy of integrated three-dimensional electroanatomic mapping with preacquired magnetic resonance images guide catheter atrial fibrillation ablation
YU Rong-hui;MA Chang-sheng;DONG Jian-zeng;LIU Xing-peng;LONG De-yong;KANG Jun-ping;FANG Dong-ping;TANG Ri-bo;HU Fu-li;HE Xiao-kui

..............page:1029-1033

Association between angiotensin-converting enzyme and endothelial nitric oxide synthase gene polymorphism and risk of coronary artery disease
JI Xiang-wu;ZHANG Ai-yuan;GUAN Li-xue;WANG Jing-xian;HUANG Jing

..............page:1024-1028

Relationship between serum vasoactive factors and plaque morphology in patients with acute coronary syndrome
KANG Wei-qiang;SONG Da-lin;GUO Xin-gui;LI Mei;TENG Jin-long;REN Guo-rui

..............page:1020-1023

Outcome of endovascular therapy of iliac, superficial femoral and popliteal arteries in 136 patients
JIANG Xiong-jing;ZHANG Hui-min;YANG Qian;WU Hai-ying;XU Bo;YANG Yue-jin;GAO Run-lin;LIU Guo-zhang;HUI Ru-tai;LIU Li-sheng

..............page:1015-1019

Clinical features of late stent thrombosis after successful sirolimus-eluting stent implantation
HE Ji-qiang;CHEN Fang;ZHANG Xiao-ling;GAO Yue-chun;LI Zheng;LI Yu;ZHANG Wei-dong

..............page:1010-1014

Clinical outcomes and safety of primary percutaneous coronary intervention combined with tirofiban therapy in patients with acute ST-segment elevation myocardial infarction
SHEN Jie;ZHANG Qi;ZHANG Rui-yan;ZHANG Jian-sheng;HU Jian;YANG Zhen-kun;ZHENG Ai-fang;ZHANG Xian;SHEN Wei-feng

..............page:1005-1009

Reduced Ca2+ current in rat cardiomyocytes transfected with troponin Ⅰ R145W mutation gene
WU Heng-fang;CHEN Xiang-jian;YANG Di;BIAN Zhi-ping;XU Jin-dan;ZHANG Ji-nan

..............page:1000-1004

Association between cardiac troponin I phosphorylation/degradation and cardiomyopathies
ZHU Chun-xia;WU Heng-fang;CHEN Xiang-jian;ZHAO Sheng;BIAN Zhi-ping;XU Jin-dan;YANG Di;YUAN Biao;ZHANG Ji-nan

..............page:996-999

Novel Val606Met mutation in beta myosin heavy chain gene in Chinese pedigrees with familiar hypertrophic cardiomyopathy
TAO Qin;YANG Jun-hua;ZHENG Dong-dong;DONG Ning-zheng;YANG Xiang-jun;SONG Jian-ping;JIANG Ting-bo;LI Hong-xia;HAN Lian-hua;ZHOU Bing-yuan;ZHAO Cai-ming;JIANG Wen-ping

..............page:992-995

Long term follow-up results of 199 patients with hypertrophic cardiomyopathy
LI Min;WANG Qi-bing;CHENG Kuan;ZHU Wen-qing;WU Hui-jun;YAN Yan;CHEN Rui-zhen;SHU Xian-hong;YANG Ying-zhen;GE Jun-bo;CHEN Hao-zhu

..............page:988-991

Experts consensus of diagnosis and treatment in pulmonary arterial hypertension(no abstract)
Chinese Society of cardiology of Chinese Medical Association;Editorial Board of Chinese Journal of Cardiology

..............page:979-987